You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A New Chloride Sweat Test for Cystic Fibrosis Screening
SBC: PolyChrome Medical, Inc. Topic: N/ADESCRIPTION (provided by applicant): The CF Quantum(r) sweat test system is a rapid, easily administered, cost effective method to diagnose cystic fibrosis (CF). The CF Quantum(r) patch (Q-patch) uses an ion-exchange reaction to produce a white precipitate which varies in size based on the chloride ion concentration of the sweat sample. Reacting the Q-patch with a chloride-containing solution (i.e ...
STTR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
Automated Method for Measurement of Hearing Sensitivity
SBC: AUDIOLOGY, INC Topic: N/AN/A
STTR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
An Electronic Workspace for the Commander
SBC: Maya Viz Topic: N/APhase I of this STTR was undertaken with a vision of an environment where commanders could dynamically reconfigure information and teams to support tasks as they aroseand where that information would easily be visualized/manipulated to allow patterns of understanding to emerge.To realize this vision, we designed an approach that involved modular software components within a collaborative workspace ...
STTR Phase II 2003 Department of DefenseDefense Advanced Research Projects Agency -
PPMP as a Ceramide Catabolism Inhibitor for Chemotherapy
SBC: AVANTI POLAR LIPIDS, INC. Topic: N/ADESCRIPTION (provided by applicant): Our goal is to develop 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) as a clinical inhibitor of ceremide catabolism, in order to enhance the anti-cancer activity of the cytotoxic retinoid, fenretinide (4-HPR). We have reported that 4-HPR increased ceramide in numerous pediatric and adult solid cancer and leukemia cell lines in vitro. We have also ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Single cycle reporter assay for quantifying HIV-1 Nab
SBC: Tranzyme, Inc. Topic: N/AN/A
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Mappicine inhibitors of HIV Ribonuclease H
SBC: FLUOROUS TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The conversion of human immunodeficiency virus (HIV) genomic RNA into DNA comprises multiple steps, each catalyzed by the multifunctional viral enzyme, reverse transcriptase (RT). Many inhibitors of HIV RT DNA polymerase activity have been discovered and ten of these are in current clinical use. In contrast, no inhibitors of HIV RT-associated RNase H are in cli ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Supported Fluorous Lipids for Triphasic Reactions
SBC: FLUOROUS TECHNOLOGIES, INC. Topic: N/AN/A
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Phage Display Tools for Automated Blood Typing
SBC: INTEGRAL MOLECULAR INC Topic: N/ADESCRIPTION (provided by applicant): Current technologies used in blood banking are extraordinarily labor intensive, prone to human error, and an order of magnitude more expensive per test that those in other clinical laboratories. Coupled with a growing shortage of skilled medical technologists, dwindling supplies of human plasma-derived phenotyping reagents, and an inherent difficulty in fully a ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
NEW TREATMENT STRATEGIES FOR HEPATITIS C
SBC: Avid Therapeutics, Inc. Topic: N/AN/A
STTR Phase I 1998 Department of Health and Human Services -
Prototype of Adjustable Systemic-Pulmonary Artery Shunt
SBC: Cardiojustable, LLC Topic: N/ADESCRIPTION (provided by applicant): This proposal is to complete the feasibility prototype of an adjustable systemic-pulmonary artery (SPA) shunt. Children with single ventricle physiology (SVP) and reduced pulmonary blood flow (PBF) are palliated with an SPA shunt until approximately 6 months of age. Current shunts are made from simple (unadjustable) polytetrafluoroethylene (PTFE) vascular gr ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health